Patent details

EP1606293 Title: CEPHALOSPORIN IN CRYSTALLINE FORM

Basic Information

Publication number:
EP1606293
PCT Application Number:
PCT/EP/2004/002667
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP047205950
PCT Publication Number:
WO/2004/085444
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CEPHALOSPORIN IN CRYSTALLINE FORM
French Title of Invention:
CEPHALOSPORINE SOUS FORME CRISTALLINE
German Title of Invention:
CEPHALOSPORIN IN KRISTALLINER FORM
SPC Number:

Dates

Filing date:
15/03/2004
Grant date:
19/08/2009
EP Publication Date:
19/08/2009
PCT Publication Date:
07/10/2004
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/12/2005
EP B1 Publication Date:
19/08/2009
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
15/03/2020
Expiration date:
15/03/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/03/2004
 
 

Name:
Basilea Pharmaceutica AG
Address:
Grenzacherstrasse 487, 4005 Basel, Switzerland (CH)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
19/08/2009
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
BERGHAUSEN Joerg
Address:
Germany (DE)

Priority

Priority Number:
03006815
Priority Date:
27/03/2003
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
C07D 501/56;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
18/02/2019
Last Annual Fee Paid Number:
16
Last Annual Fee Paid Amount:
230 Euro
Payer:
PATRIX IP SERVICES
Filing date Document type Number of pages